Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL5P29 is a processed pseudogene of the ribosomal protein L5 gene (RPL5). Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition events. RPL5P29 does not produce a functional protein and is not involved in protein synthesis or known human disease pathways. In humans, the functional RPL5 gene encodes a component of the 60S ribosomal subunit (see: 60S ribosomal protein L5), but its pseudogenes, including RPL5P29, are generally dispersed throughout the genome and lack protein-coding potential[1][2][3].\n\nEssentially, RPL5P29 is not an active gene or protein, has no established biological role, and is not a therapeutic target. This nomenclature is correct, but functionally, this entity is a pseudogene consistent with convention for ribosomal protein pseudogenes[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 29 (RPL5P29).